Pulmonary vascular disease & thromboembolism

Quality and rapidity of anticoagulation in patients with acute pulmonary embolism undergoing mechanical thrombectomy

Am Heart JPublished Observational study

Authors' conclusion

The salient findings of our study showed that only a minority of patients (14.3%) were in the therapeutic range by ACT at the time of MT (primary outcome).

Study context

Population
Intermediate-risk PE patients undergoing mechanical thrombectomy
Outcome
Proportion achieving therapeutic anticoagulation (by ACT)
Follow-up
Time of mechanical thrombectomy

Main finding

As reported in the abstract

Therapeutic AC by ACT at time of MT

In therapeutic range by ACT at time of mechanical thrombectomy (MT)

14.3%

Observational data: associations, not effects.

Further findings

Subtherapeutic after initially reaching therapeutic anticoagulation (AC)

Subtherapeutic after initial therapeutic AC
18.2%

Supratherapeutic AC at some point before MT

Supratherapeutic AC before MT
43%

Therapeutic AC at 6 hours

Therapeutic AC at 6 hours
43%
  • Less than half

Original publication

Quality and rapidity of anticoagulation in patients with acute pulmonary embolism undergoing mechanical thrombectomy. Am Heart J. Published January 2024. doi:10.1016/j.ahj.2023.10.001

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.